Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2025: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2024: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2023: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Research at the Start |
Using PD-1 knockout mouse as model, we aim to identify novel serum metabolites associated with immune activation and evaluate their immune regulatory properties. These compounds can be used as biomarkers for anti-PD-1 tumor therapy, and they can be targeted for the modulation of immune responses.
|